This session will update oncologists about the contemporary management of lymphoma and will address the following:

Radiation Oncologists today are inundated with marketing messages claiming the high accuracy of one respiratory management technique compared to others in the market.

The specific scenarios will include men with newly diagnosed localized, locally advanced, post-operative pT3,4 and/or margin + disease in the setting of an undetectable PSA in addition to post-operative or post-radiation PSA recurrence.

There will be four components to the program: 1. Quality in radiotherapy: why there’s more to do. 2. Managing for quality: equipment. 3. Managing for quality: people. 4. Managing for quality: processes.

This session will cover key concepts related to implementing intensity modulated radiotherapy (IMRT) and stereotactic body radiotherapy (SBRT) gastrointestinal (GI) cancers. Updates on clinical outcome data using IMRT and SBRT, including survival and toxicity, will be presented.

Each member of the multi-disciplinary panel will present a current controversy in the management of CNS tumors including diffuse gliomas, glioblastoma, re-irradiation, interpreting imaging changes following novel therapies, and brain metastases as well as provide input on their interpretation of

This course will describe the presentation, evaluation, and management of patients with oropharyngeal cancers, especially with regard to the importance of multidisciplinary management of patients with HPV-related cancers.

Rare gynecologic tumors pose a significant challenge to even the most experienced clinicians as there are few published guidelines on how best to manage these often complex presentations.

This course will focus on cases that illustrate difficult challenges in the loco-regional management of cervical cancer. Clinical cases of will provide the basis for short presentations and subsequent discussion.